Clinical Trials Group

ctgcro.com

CTG (Clinical Trials Group) is a private contract research organization (CRO) experienced and specialized in conducting all phases (I-IV) clinical trials in various therapeutic areas. For over 10 years, many sponsors have been benefiting from CTG's global and local scientific, regulatory and information management expertise achieving timely and high-quality clinical trials data. With an experienced and reliable team on board, CTG is a confirmed trusted partner in clinical research which is enforced by high working standards of Quality Control (QC) and Quality Assurance (QA).

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

TRANSACTION DATA SYSTEMS ACHIEVES KLOUDSCRIPT, A CLOUD-BASED SPECIALTY PHARMACY SOLUTION

Transaction Data Systems | November 25, 2020

news image

Exchange Data Systems (TDS), the pioneer in drug store programming answers for the network drug store market, today reported the obtaining of KloudScript, a strength drug store care arrangement. Right now 39% of network drug stores apportion a type of strength prescriptions, agreeing the National Community Pharmacy Association. Interest for strength meds has been consistently ascending to treat explicit sickness states and the constantly sick. With the maturing populace and the ex...

Read More

SEVEN PHARMACEUTICAL STOCKS THAT STAND TO WIN BEYOND THE COVID-19 CHASE

InvestorPlace | July 15, 2020

news image

It’s easy to miss the forest for the trees in markets like this. Especially when it comes to pharmaceutical stocks. What I mean is that, in some sectors, there are great stocks that get overlooked because a few of them are working on event-driven issues, while others are creating long-term solutions to major trends. This is especially true in the pharmaceutical and biotech spaces right now. Maybe it’s because the Kentucky Derby was postponed, but people are betting on ...

Read More

Business Insights, PHARMACY MARKET

ENDO LAUNCHES AUTHORIZED GENERIC VERSION OF NOXAFIL® (POSACONAZOLE) ORAL SUSPENSION

Prnewswire | April 04, 2023

news image

Endo International plc announced that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the authorized generic (AG) version of Merck's Noxafil® (posaconazole) 200 mg/5 mL oral suspension in the U.S. "Our partnership with Merck underscores our reputation as an industry-leading supplier," said Scott Sims, Senior Vice President and General Manager, Injectable Solutions & Generics at Endo. "This newly available Noxafil® AG do...

Read More

Pharmacy Market

MEDNOW ANNOUNCES PHARMACY PARTNERSHIP AGREEMENT WITH SERVICEPLUS, A NATIONAL TOTAL REWARDS PLATFORM OPERATED BY PIPSC

Businesswire | June 20, 2023

news image

Mednow Inc. Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has executed a Preferred Pharmacy Agreement with ServicePlus, a leading provider of Member Benefit and rewards services. The agreement allows ServicePlus members to leverage enhanced services and preferred pricing from Mednow digital pharmacy and healthcare platform to its clients and plan members. "Mednow is thrilled to partner with ServicePlus to expand access to virtual pharmac...

Read More
news image

Pharmacy Market

TRANSACTION DATA SYSTEMS ACHIEVES KLOUDSCRIPT, A CLOUD-BASED SPECIALTY PHARMACY SOLUTION

Transaction Data Systems | November 25, 2020

Exchange Data Systems (TDS), the pioneer in drug store programming answers for the network drug store market, today reported the obtaining of KloudScript, a strength drug store care arrangement. Right now 39% of network drug stores apportion a type of strength prescriptions, agreeing the National Community Pharmacy Association. Interest for strength meds has been consistently ascending to treat explicit sickness states and the constantly sick. With the maturing populace and the ex...

Read More
news image

SEVEN PHARMACEUTICAL STOCKS THAT STAND TO WIN BEYOND THE COVID-19 CHASE

InvestorPlace | July 15, 2020

It’s easy to miss the forest for the trees in markets like this. Especially when it comes to pharmaceutical stocks. What I mean is that, in some sectors, there are great stocks that get overlooked because a few of them are working on event-driven issues, while others are creating long-term solutions to major trends. This is especially true in the pharmaceutical and biotech spaces right now. Maybe it’s because the Kentucky Derby was postponed, but people are betting on ...

Read More
news image

Business Insights, PHARMACY MARKET

ENDO LAUNCHES AUTHORIZED GENERIC VERSION OF NOXAFIL® (POSACONAZOLE) ORAL SUSPENSION

Prnewswire | April 04, 2023

Endo International plc announced that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the authorized generic (AG) version of Merck's Noxafil® (posaconazole) 200 mg/5 mL oral suspension in the U.S. "Our partnership with Merck underscores our reputation as an industry-leading supplier," said Scott Sims, Senior Vice President and General Manager, Injectable Solutions & Generics at Endo. "This newly available Noxafil® AG do...

Read More
news image

Pharmacy Market

MEDNOW ANNOUNCES PHARMACY PARTNERSHIP AGREEMENT WITH SERVICEPLUS, A NATIONAL TOTAL REWARDS PLATFORM OPERATED BY PIPSC

Businesswire | June 20, 2023

Mednow Inc. Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has executed a Preferred Pharmacy Agreement with ServicePlus, a leading provider of Member Benefit and rewards services. The agreement allows ServicePlus members to leverage enhanced services and preferred pricing from Mednow digital pharmacy and healthcare platform to its clients and plan members. "Mednow is thrilled to partner with ServicePlus to expand access to virtual pharmac...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us